CTOs on the Move

Frederick Memorial Healthcare System

www.fmh.org

 
Frederick Memorial Healthcare System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Frederick Memorial Healthcare System is based in Frederick, MD. You can find more information on Frederick Memorial Healthcare System at www.fmh.org
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.fmh.org
  • 400 W 7th St
    Frederick, MD USA 21701
  • Phone: 240.566.3300

Executives

Name Title Contact Details

Similar Companies

Alliance Clinical Associates

Alliance Clinical Associates is a mental health clinic that offers a wide range of services to address emotional and mental health problems. They provide services to children, teens, adults, and the aging population from a faith-sensitive perspective.

Easy Choice Health Plan

Easy Choice Health Plan is a Newport Beach, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vital Proteins

We believe that whole food based nutrition containing collagen is essential for one`s overall health, beauty, fitness and well-being. Our ancestors utilized sustainable whole animal nutrition, which provided an abundant amount of collagen. Over the past century modern food processing has removed this natural and healthy protein from our diets. Collagen is vital for our body and is the basic building block of skin, hair, nails, bones and joints. We promote optimal health, beauty, vibrant youth, and overall wellness with our products. We are dedicated to providing 100% natural, whole food proteins that support animal well-being and sustainable eco-friendly practices. Our happy cows openly graze on lush natural grass pastures providing the highest quality of protein.

Wrangell Medical Center

Wrangell Medical Center is a Wrangell, AK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ProKidney

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III